Piramal Pharma Limited has informed the Exchange about Schedule of meet
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has informed the stock exchanges about its upcoming schedule of meetings with analysts and institutional investors. Two meetings are planned in Mumbai: one on May 22, 2025 with the MACM India Conference, and another on May 28, 2025 at the B&K Securities Annual Investor Conference. Both will involve in-person group and one-on-one interactions with investors. The filing was made under SEBI Listing Regulations and notes that dates may change due to scheduling exigencies.
This is a routine disclosure about investor engagement activities and is unlikely to have any direct impact on the stock price. It signals continued outreach to institutional investors, which is normal corporate practice.